Cadoret Global

What Cadoret Global does

Cadoret Global Inc. is a privately held US-based consulting firm founded in 2019 and headquartered in Cumberland, Rhode Island, that provides Quality and GxP compliance services to emerging pharmaceutical and biotechnology companies. The firm is led by founder and CEO Enith Morillo and operates with a small team (11-50 employees) of vetted expert consultants. Its stated purpose is to guide life-sciences clients through the regulatory and operational complexity of drug development, from pre-clinical stages through clinical success, with explicit emphasis on "phase-appropriate" quality systems that scale with a sponsor's development maturity.

The service catalog is a single professional-services offering rather than a discrete product suite, comprising phase-appropriate scalable quality systems, vendor management and quality oversight, foreign and domestic GxP audits, batch record review and product release, clinical supply chain management, EU QP strategy and independent audits, and Privacy Governance. The firm claims cross-jurisdictional regulatory expertise spanning FDA, EMA, TGA, PIC/S, MHRA, ICH, Health Canada, PMDA, and USP standards. Marketing is conducted primarily through the company website, which serves as both an industry expertise showcase (FY2022 BIMO Compliance Snapshot referencing FDA enforcement statistics) and a testimonial repository, supplemented by direct contact channels. No API, proprietary software platform, patents, certifications, awards, or external funding rounds are disclosed.

The revenue model is professional services delivered through custom consulting engagements — likely project or retainer-based — to a mix of enterprise (Worldwide Clinical Trials, Bioassay, Medspace, neuroscience and pharma sponsors) and small/mid-sized biotech clients. Testimonials indicate multi-year embedded engagements and successful exit support (a small-pharma client acquired by big pharma with Cadoret's due-diligence contribution). Distribution is direct; the firm markets globally in principle, but operations and named customers appear to be primarily North America-anchored.

Name

Cadoret Global

Legal name

Cadoret Global Inc.

Website

https://cadoretglobal.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

11–50 employees

Short description

Cadoret Global is a private US-based consulting firm that provides Quality and GxP compliance services to emerging pharmaceutical and biotech companies, supporting them from pre-clinical drug development through clinical success with phase-appropriate quality systems, audits, and regulatory strategy.

Ownership category

akta.pro rank

Product category

Pharmaceutical Regulatory & Quality Consulting

NAICS

Other Scientific and Technical Consulting Services (54169)

SIC

Services-Management Consulting Services (8742)

akta.pro primary industry

Clinical Quality Assurance (GCP QA, TMF/QMS oversight) (HLAGAKAI)

akta.pro secondary industries

Regulatory Strategy & Global Submissions (IND/CTA/NDA/BLA/MAA) (HLAGAKAA), Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM)

Keywords

• GxP compliance consulting
• Pharmaceutical quality systems
• Regulatory compliance auditing
• Biotech drug development
• Vendor management audits

Headquarters

HQ city

Cumberland

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Quality and GxP Consulting Services: Consulting services provided to pharmaceutical and biotech companies for quality systems, vendor management, GxP audits, batch record review, clinical supply chain management, EU QP strategy, and privacy governance. The revenue model is professional services-based, likely project or retainer engagements.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Cadoret Global provides Quality and GxP compliance consulting services to emerging pharmaceutical and biotech companies. Its offerings include phase-appropriate scalable quality systems, vendor management and quality oversight, foreign and domestic GxP audits, batch record review and product release, clinical supply chain management, EU QP strategy and independent audits, and privacy governance. Services are delivered through tailored consulting engagements that span pre-clinical through clinical success stages of drug development.

Product overview

Cadoret Global is a single-service consulting firm offering Quality and GxP compliance consulting services for emerging pharmaceutical and biotech companies. Their offering is a unified consulting service rather than a platform with distinct products. The service encompasses phase-appropriate, scalable quality systems, vendor management and quality oversight, foreign and domestic GxP audits, batch record review and product release, clinical supply chain management, EU QP strategy and independent audits, and Privacy Governance. They provide strategic and tactical support to help clients navigate the regulatory landscape from pre-clinical development through clinical success.

Differentiator

Problem solved

Functional benefit

Products and services

• Quality and GxP Compliance Consulting End-to-end Quality and GxP compliance consulting service for emerging pharmaceutical and biotech companies, covering phase-appropriate scalable quality systems, vendor management and quality oversight, foreign and domestic GxP audits, batch record review and product release, clinical supply chain management, EU QP strategy and independent audits, and privacy governance across the drug development lifecycle from pre-clinical through clinical success.

Quantifiable outcome

• Successfully supported client's acquisition by a big pharma company through due diligence process

Named customers7 records

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Three partnerships are on record, tiered minor.

• Worldwide Clinical TrialsminorStrategic or Co-development PartnerWorking relationship indicated through client logo display on Cadoret Global website, suggesting collaborative engagement in clinical trials support services.
• BioassayminorStrategic or Co-development PartnerClient partnership indicated through logo display on website, suggesting ongoing quality and compliance consulting relationship.
• MedspaceminorStrategic or Co-development PartnerClient partnership indicated through logo display on website, suggesting collaborative support for pharmaceutical development activities.

Scale indicators4 records

Recent moves5 records

Expansion highlights3 records

Broad incumbents

• IQVIA: IQVIA is a global CRO with broad regulatory and quality consulting practices embedded in its clinical services portfolio. It represents the enterprise incumbent that small-pharma clients typically migrate to as their development programs scale.
• ICON plc: ICON is a global CRO with regulatory and quality consulting capabilities serving pharma and biotech. It competes with Cadoret Global for quality and GxP work, especially as biotech clients advance into later-stage trials.
• Medpace: Medpace is a mid-to-large CRO offering full-service clinical development with embedded regulatory and quality expertise. It is both a listed Cadoret Global client and a broader competitor for quality/GxP work tied to clinical trial execution.
• Parexel International: Parexel is a global CRO offering regulatory strategy and quality consulting as part of its full-service clinical offering. It is comparable to Cadoret Global as a broader incumbent that small-pharma clients often adopt at later stages.
• Charles River Laboratories: Charles River is a broad life sciences services firm offering manufacturing, quality, and regulatory consulting. It overlaps with Cadoret Global on quality and GxP services but at much greater scale and as part of a wider portfolio.

Direct peers

• ProPharma Group: ProPharma Group is a regulatory, compliance, and pharmacovigilance consultancy serving pharma and biotech across the product lifecycle. It is a direct peer to Cadoret Global in GxP quality and regulatory consulting for small and mid-size pharma clients.
• Camargo Pharmaceutical Services: Camargo is a regulatory consulting firm specializing in 505(b)(2) and ANDA pathways, serving small and mid-size pharma. It is comparable to Cadoret Global in targeting development-stage pharma clients needing regulatory and quality support.
• Validant: Validant provides regulatory, quality, and compliance consulting specifically targeted at small and emerging pharma. It competes head-to-head with Cadoret Global for the same niche of development-stage biotech and specialty pharma clients.
• PharmaLex (Cencora): PharmaLex, now part of Cencora, provides regulatory affairs, quality management, and pharmacovigilance consulting. It directly competes with Cadoret Global in GxP/QA consulting, particularly for emerging biotech needing EU and global regulatory strategy.
• Lachman Consultants: Lachman Consultants is an FDA compliance and GMP quality systems consultancy serving pharma and biotech. It is a direct competitor to Cadoret Global in GxP audits, quality system design, and remediation work.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/cadoret-global

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cadoret Global